Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Science Ltd
    Pediatric anesthesia 7 (1997), S. 0 
    ISSN: 1460-9592
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Midazolam was applied transmucosally in 47 children randomly assigned to three different groups. Group N received 0.2 mg·kg−1 nasally, group R 0.5 mg·kg−1 rectally, and group S 0.2 mg·kg−1 sublingually. All groups were treated 60 min prior to a planned i.v. puncture with EMLA®. Reliable and valid psychological parameters (such as emotional situation, shivering, awareness, respiratory rate and facial colour) were scored after premedication and before and after i.v. puncture, 20 min after premedication and until induction. A blood sample was drawn 10, 30 and 60 min after premedication and the levels of midazolam, alpha-hydroxy-midazolam, ACTH, glucose and cortisol were measured. In all three groups the plasma levels of midazolam 10 min after premedication were higher than 70 ng·ml−1 (accepted as a sedative level). 30 min after premedication the midazolam level in the sublingual group was statistically significantly higher than in the nasal group and the psychological parameters in all three groups were significantly changed (10 min after premedication). The psychological parameters were not significantly different between the three groups over the whole study. Sublingual premedication has some advantages (most readily accepted, highest plasma levels and lowest deviations) and could be the first choice in premedication of children. All three transmucosal applications are safe and well accepted, although nasal application was rejected by two of the children.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1365-2044
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Postoperative nausea and vomiting (PONV) are frequent and unpleasant symptoms. This prospective study aimed to assess the efficacy of a multimodal approach to prevent PONV, and patient satisfaction using the willingness-to-pay method. Two validated risk scores were applied to forecast the individual risk for PONV in 900 consecutive patients of whom 108 were identified as high-risk patients (predicted risk: 79–87%). High-risk patients received multimodal anti-emetic prophylaxis: total intravenous anaesthesia with propofol, high fractional inspired oxygen (80%), omission of nitrous oxide, dexamethasone 8 mg, haloperidol 10 µg.kg−1, and tropisetron 2 mg. Of the remaining patients with low or moderate risk for PONV, a random sample of 71 females received balanced propofol-desflurane anaesthesia without prophylactic anti-emetics. All patients were interviewed 2 and 24 h after surgery for occurrence of nausea and vomiting. Patient satisfaction was measured using the willingness-to-pay method. The incidence of PONV (95%-confidence interval) in the control-group was 41% (29–51%), slightly lower than predicted by the risk scores (53–57%). The multimodal anti-emetic approach reduced the predicted risk (79–87%) in the high risk-group to 7% (3–14%). This was associated with a high willingness-to-pay median (25th/75th percentile) of £84 (£33–184) in the multimodal anti-emetic grouped compared to £14 (£4–30) in the control group. A multimodal anti-emetic approach can considerably reduce the incidence of PONV in high-risk patients and is associated with a high patient satisfaction as measured by the willingness-to-pay method.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-055X
    Keywords: Schlüsselwörter Closed-Loop-Systeme ; Neuronales Netzwerk ; Muskelrelaxans ; Mivacurium ; Key words Closed-Loop-control ; Neural network ; Muscle relaxants ; Mivacurium
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract There are many closed-loop control systems for muscle relaxants reported, but only a few could cope with the introduction of the latest shorter acting neuromuscular blocking drugs. These new muscle relaxants such as mivacurium require a fast adapting closed-loop system for controlling an adequate infusion. Methods. After approval of the local ethics committee and having the patients’ informed consent a total number of 75 patients [ ASA I and II] were included in the study and assigned either to a training-, prediction-, prediction-/feedback- or a validationphase, as needed. Anaesthesia was induced and maintained with propofol in a TCI-mode with a plasma level of 3 to 5 µg/ml and 0.1 mg fentanyl boli as needed in all patients. In the last validation phase, having 20 patients, the prediction error and the error of the whole system was taken and analysed. Results. A closed-loop system using a neural network as a predictor could be established. In the final validation phase constisting of 20 patients the mean square prediction error was found to be 0.1%±0.2% [ mean±SD]. The mean square error of the whole system was 0.55%±0.59% [ mean±SD]. Conclusions. A closed-loop system for control of a mivacurium infusion could be established. The system proofed to be reliable for a closed-loop infusion of mivacurium in order to maintain a predefined degree of neuromuscular blockade of 95% during routine surgery. The performance of the described controller is comparable to all recent attempts and could therefore be useful for scientific studies. It should be futher validated and esthablished for other muscle relaxants, as well.
    Notes: Zusammenfassung In den vergangenen Jahren wurden unterschiedliche closed-loop-Systeme mit modell-prädiktivem Charakter zur Regelung von Muskelrelaxanzien beschrieben. Seit der klinischen Einführung von Mivacurium ist eine dank seiner kurzen Halbwertszeit für den Regelungsansatz sehr geeignete Substanz verfügbar, deren Dauerinfusion bisher nur von wenigen Systemen geregelt werden kann. Der Einsatz eines neuronalen Netzwerks als Prädiktor für eine solche Regelung soll in der vorliegenden Arbeit untersucht werden. Methodik. 75 Patienten, die sich einem abdominal chirurgischen Eingriff in Vollnarkose unterziehen mußten, wurden nach den Erfordernissen der Synthese des neuronalen Netzwerks der Trainings-, reinen Prädiktions-, der Prädiktions/Regelungs- und der Validierungsphase zugeteilt. Eine standardisierte Narkose wurde mit Propofol in einem TCI-Modus mit 3–5 µg/ml und 0,1 mg Fentanylboli aufrechterhalten. Die Regelung des Systems im Hinblick auf Prädiktions- bzw. gesamt Regelungsfehler wurde bei den 20 Patienten mit einem T1-Wert von 5% in der Validierungsphase statistisch untersucht. Ergebnisse. Es konnte eine Regelung mit einem neuronalen Netzwerk als Prädiktor zur Regelung einer Mivacuriuminfusion synthetisiert werden. Das Quadrat des gemittelten Prädiktionsfehlers über alle 20 Patienten der Validierungsphase lag bei 0,1% mit einer Standardabweichung von 0,2%. Die Abweichung der Sollgröße von der Istgröße wurde gemessen. Hier wurde der tatsächliche T1-Wert vom Ziel T1-Wert [ 5% bzw. 95%ige Blockade] berechnet. Der mittlere quadratische Fehler des gesamten Systems betrug hierbei 0,55%, die Standardabweichung 0,59%. Schlußfolgerung. Der Einsatz eines neuronalen Netzwerks erlaubt es, eine Mivacuriuminfusion exakt zu steuern und damit die neuromuskuläre Blockade über den Zeitraum einer Operation auf einem vorgegebenen Relaxationsniveau zu halten. Die Ergebnisse sind mit denen anderer Reglungsansätze vergleichbar, bei einer deutlich verbesserten Prädiktionsfunktion. Der Einsatz dieses Systems ist im Rahmen von wissenschaftlichen Studien, die eine konstante Relaxationstiefe erfordern, denkbar. Eine Ausweitung auf andere Muskelrelaxanzien wäre auch wünschenswert.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1432-055X
    Keywords: Schlüsselwörter Mivacurium ; geteilte Dosis ; Intubationsbedingungen ; Erholung ; TIVA ; Key words Mivacurium ; Divided dose ; Intubation ; Recovery ; TIVA
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract The aim of this study was to compare the intubating conditions of a mivacurium-induced neuromuscular block 90 s after a divided administration with three different methods of induction of anaesthesia. Methods. After approval by the local ethics committee, we investigated 36 ASA I and II patients undergoing a 2-h scheduled, elective surgery, in whom a TIVA was induced by one of three different drugs, edomidate, methohexital or propofol. After stable anaesthesia was reached, 0.15 mg/kg and 0.1 mg/kg of mivacurium, spaced 30 s apart, was injected. Endotracheal intubation was performed 90 s after the first micacurium injection and the intubation conditions were graded (1: excellent, 2: good, 3: poor; 4: impossible). The neuromuscular function was stimulated every 20 s by a nerve stimulator in a train-of-four (TOF) pattern, and the time to complete distinction of a TOF response as well as the time of reoccurrence of the first twitch was taken. A minute prior to injection of the relaxant and every minute for 5 min, the systolic and diastolic blood pressure, mean arterial pressure (MAP) and heart rate were measured. The neuromuscular block was maintained with a mivacurium infusion on a level of one twitch response. After cessation of the mivacurium infusion we recorded the time of reappearance of the second, third and fourth twitch responses. Results. All patients could be intubated 90 s after mivacurium except for one, who was excluded for abnormal difficult intubation conditions. The etomidate group had significantly (χ2 test) worse intubation grades than the methohexital group. In none of the groups did we observe any significant cardiovascular response due to the mivacurium injection, neither in blood pressure nor in heart rate. All groups showed similar onset of the maximal neuromuscular block (4±1.8 min) and recovery of the first TOF reaction (11.3±3.4 min). There was no difference in recovery from neuromuscular block maintained by infusion at the end of surgery. Conclusions. A dose of mivacurium 3.57 times the ED95 does not produce any haemodynamic instability, if it is divided into two parts to induce a TIVA. After this dose, all patients could be safely intubated within 90 s. A prolongation of the neuromuscular block after higher mivacurium doses could not be seen, and this dose did not produce a more rapid onset of the maximal block in any group. The time for recovery from a mivacurium infusion did not differ among the groups. Etomidate, due to its short half-life, seems not ideal for induction of a TIVA together with mivacurium in the dosage used. Mivacurium meets the demands of good controllability as required for a TIVA and can be recommended for a 90-s injection-intubation interval as well as for maintenance of the neuromuscular block.
    Notes: Zusammenfassung Eine geteilte 3,57fache Mivacurium ED 95 ist geeignet, die Intubation im Rahmen einer TIVA-Einleitung mit Etomidat, Methohexital oder Propofol bereits 90 s nach Injektion mit guten bis sehr guten Intubationsgraden zu ermöglichen. Die Aufteilung dieser Mivacuriumdosis in 0,15 mg/kg KG und weitere 0,1 mg/kg KG 30 s später verhindert die nach Benzylisochinolinen zu erwartenden Histamin-bedingten negativen Kreislaufreaktionen. Auch eine höhere Dosis als die zweifache ED 95 führt nicht zu einem verlängerten neuromuskulären Block, jedoch auch nicht zu einer Verkürzung bis zum Ausbleiben einer Train-of-four Antwort.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1432-055X
    Keywords: Schlüsselwörter Perioperativer Myokardinfarkt ; Akut-PTCA ; Thrombolyse ; kardiogener SchockPerioperative myocardial infarction ; Acute-PTCA ; Thrombolytic therapy ; Cardiogenic shock ; Key words Perioperativer Myokardinfarkt ; Akut-PTCA ; Thrombolyse ; kardiogener SchockPerioperative myocardial infarction ; Acute-PTCA ; Thrombolytic therapy ; Cardiogenic shock
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract The mortality of perioperative myocardial infarction is still high and according to recently published data amounts to 17 to 42%. In the seventies introduction of thrombolytic therapy has led to a dramatic reduction in mortality of non-perioperative myocardial infarction. However, in the perioperative situation thrombolytic therapy remains to be problematic in most cases because of expected severe bleeding complications. In the last 4–6 years acute-PTCA has been established in the therapy of acute myocardial infarction. Up to date no data are available concerning the effect of acute-PTCA on mortality of perioperative myocardial infarction. Nevertheless it can be assumed, that acute-PTCA will lead to a considerable reduction in mortality of perioperative myocardial infarction. Therefore, in patients with significant perioperative myocardial infarction immediate coronary angiography and, if indicated, acute-PTCA should be performed. In principle, thrombolytic therapy is considered to be contraindicated in the intra- or postoperative situation. However, if coronary angiography and PTCA are not possible, thrombolysis might be taken into consideration, in particular if the expected bleeding complications are small in relation to the expected benefit of thrombolysis. Since acute-PTCA has been shown to remarkably reduce mortality in patients with cardiogenic shock after acute myocardial infarction, this group of patients should be especially considered.
    Notes: Zusammenfassung Die Letalität des perioperativen Myokardinfarkts ist auch nach neueren Untersuchungen mit 17–42% ausgesprochen hoch. Während die thrombolytische Therapie Ende der 70er Jahre zu einer drastischen Senkung der Letalität des nicht-perioperativen Myokardinfarkts geführt hat, blieb für die perioperative Situation die Thrombolyse wegen der zu erwartenden Blutungskomplikationen im allgemeinen ausgeschlossen. In den letzten Jahren hat sich neben der Thrombolyse die Akut-PTCA (Percutane Transluminale Coronare Angioplastie) in der Therapie des Myokardinfarkts etabliert. Bisher liegen keine Studien zum Einfluß der Akut-PTCA auf die Letalität des perioperativen Myokardinfarkts vor. Dennoch ist davon auszugehen, daß die Akut-PTCA zu einer erheblichen Reduktion der Letalität des perioperativen Infarkts führt. Somit sollte bei jedem Patienten mit einem größeren oder hämodynamisch beeinträchtigenden Myokardinfarkt eine sofortige Koronarangiographie und ggf. eine Akut-PTCA durchgeführt werden. Die thrombolytische Therapie ist in der intra- und postoperativen Phase im allgemeinen kontraindiziert. Sind jedoch logistisch die Voraussetzungen zur Akut-PTCA nicht gegeben und sollte ein größerer Infarkt bzw. eine bedrohliche Situation vorliegen, kann unter Abwägung des zu erwartenden Blutungsrisikos und des zu erwartenden Nutzens eine Thrombolyse in Betracht gezogen werden. Besonders bei Patienten, die infolge des Myokardinfarkts einen kardiogenen Schock entwickelt haben, hat die Akut-PTCA zu einer erheblichen Reduktion der sonst ausgesprochen hohen Krankenhausletalität geführt und läßt auch bei dem perioperativen Infarkt mit kardiogenem Schock eine deutliche Reduktion der Letalität erwarten.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    Intensivmedizin und Notfallmedizin 36 (1999), S. 612-618 
    ISSN: 1435-1420
    Keywords: Key words MRSA ; Synercid ; VRSA ; Decontamination ; Schlüsselwörter MRSA ; Synercid ; VRSA ; Dekontamination
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Diese Übersichtsarbeit zeigt den aktuellen Stand der Behandlung und Prophylaxe bei Infektion mit Methicillin-resistenten Staphylococcus-aureus-Stämmen (MRSA) und den seit kurzem aufgetretenen Vancomycin-resistenten Staphylokokken (VRSA) unter besonderer Berücksichtigung intensivmedizinischer Probleme. Dargestellt werden die hygienischen bzw. Isolationsmaßnahmen, welche zum Behandlungskonzept einer MRSA-Infektion im Zuge einer Krankenhausepidemie gehören, wie auch die chemotherapeutischen Möglichkeiten in der Therapie einer MRSA-Infektion sowohl lokal als auch systemisch, unter besonderer Berücksichtigung der kurz vor ihrer europaweiten Einführung stehenden Substanz Quinupristin/ Dalfopristin (Synercid, Rhone-Poulenc RP 59500) und deren Wirkungsspektrum bei VRSA- und MRSA-Infektion.
    Notes: Summary The review shows the development in the prophylactics and therapy of methicillin (multi)-resistant Staphylococcus aureus (MRSA) and the lately emergenced vancomycin-resistant Staphylococcus aureus (VRSA) strains the lately emergenced. A state of the art decontamination and isolation guideline with a special emphasis on critical care patients is given. Also the article reviews the currently used antibiotic drugs for local and systemic treatment of MRSA infection. The most important systemic administered drugs are discussed with a focus on glycopeptides. Quinupristin/ Dalfopristin (Synercid®, RP 59500) as a substance, which is currently being clinically investigated and is close to its registration, is also introduced and quoted.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...